# SARS-CoV-2 vaccine effectiveness assessment (synthetic dataset 10k)

Description: Synthetic data set to test the causal model proposed by the baseline use case in BY-COVID WP5 assessing the effectiveness of the SARS-CoV-2 vaccine (10k registries and 650k registries)

## Bibliographic

Published | 26-01-2023
Keywords | synthetic data dataset covid-19 vaccines effectiveness causal model
Funder | European Commission BY-COVID - Beyond COVID (101046203)
License | CC BY 4.0

## Coverage

### Temporal

Begin | 01-01-2020
End | 31-12-2024

### Spatial

## Attributes

Name | Description | Unit
--- | --- | ---
`person_id` | Pseudoid of the person included in the cohort |
`age_nm` | Age of the person included in the cohort (at the time of entering the cohort) | years
`sex_cd` | Sex of the person included in the cohort (at the time of entering the cohort) |
`socecon_lvl_cd` | Socioeconomic level of the person in the cohort (at the time of entering the cohort) |
`residence_area_cd` | Area of residence of the person included in the cohort (NUTS 3) (at the time of entering the cohort) |
`country_cd` | Country of residence of the person included in the cohort (at the time of entering the cohort) |
`foreign_bl` | Is the country of residence different from the country that is doing the analyses? |
`exitus_dt` | Date of death of the person (if the person has died) |
`exitus_bl` | Date of death of the person (if the person has died during the period of study) |
`essential_worker_bl` | Is the person included in the cohort an essential worker? (at the time of entering the cohort) |
`institutionalized_bl` | Is the person included in the cohort institutionalized? (at the time of entering the cohort) |
`dose_1_brand_cd` | Brand of first dose of the vaccine |
`dose_1_dt` | Date of the first dose of the vaccine |
`dose_2_brand_cd` | Brand of second dose of the vaccine |
`dose_2_dt` | Date of the second dose of the vaccine |
`dose_3_brand_cd` | Brand of third dose of the vaccine |
`dose_3_dt` | Date of the third dose of the vaccine |
`number_doses` | Number of doses (independently of the vaccine brand) received by a person during the period of study |
`fully_vaccinated_dt` | Date on which the person included in the cohort is considered fully vaccinated |
`fully_vaccinated_bl` | Is the person included in the cohort fully vaccinated? |
`vaccination_schedule_cd` | Vaccine types received for 1st and 2nd dose concatenated with hyphen |
`confirmed_case_dt` | Date of diagnosis or date of test result positive of any known/confirmed infection after 2021-01-01 (SARS-CoV-2 vaccine roll-out) for non-vaccinated or after the person is considered fully vaccinated (see 'fully_vaccinated_dt') if vaccinated |
`confirmed_case_bl` | Is the person included in the cohort a confirmed COVID-19 case? |
`previous_infection_dt` | If the person experienced a confirmed infection before 2021-01-01 (SARS-CoV-2 vaccine roll-out) or before being considered fully vaccinated (see 'fully_vaccinated_dt') |
`previous_infection_bl` | Did the person experience a confirmed infection proceeding the last confirmed infection? |
`test_type_cd` | Type of COVID-19 test used to detect the last known SARS-CoV-2 infection (i.e. first positive test for SARS-CoV-2) |
`variant_cd` | Identified variant (WHO label) for last known SARS-CoV-2 infection |
`diabetes_bl` | Does the person included in the cohort suffer from type II diabetes (at the time of entering the cohort)? |
`obesity_bl` | Does the person included in the cohort suffer from obesity (at the time of entering the cohort)? |
`heart_failure_bl` | Does the person included in the cohort suffer from heart failure (at the time of entering the cohort)? |
`copd_bl` | Does the person included in the cohort suffer from chronic lung disease (at the time of entering the cohort)? |
`solid_tumor_without_metastasis_bl` | Does the person included in the cohort suffer from solid cancer without metastatis (at the time of entering the cohort)? |
`chronic_kidney_disease_bl` | Does the person included in the cohort suffer from chronic kidney disease (at the time of entering the cohort)? |
`sickle_cell_disease_bl` | Does the person included in the cohort suffer from sickle cell disease (at the time of entering the cohort)? |
`hypertension_bl` | Does the person included in the cohort suffer from hypertension (at the time of entering the cohort)? |
`chronic_liver_disease_bl` | Does the person included in the cohort suffer from chronic liver disease (at the time of entering the cohort)? |
`blood_cancer_bl` | Does the person included in the cohort suffer from blood cancer (leukemia) (at the time of entering the cohort)? |
`transplanted_bl` | Is the person included in the cohort a transplant patient (i.e. solid organ transplantation) (at the time of entering the cohort)? |
`hiv_infection_bl` | Does the person included in the cohort suffer from a HIV infection (at the time of entering the cohort)? |
`primary_immunodeficiency_bl` | Does the person included in the cohort suffer from a primary immuno deficiency disease (lymphoma) (at the time of entering the cohort)? |
`immunosuppression_bl` | Does the person included in the cohort suffer from drugs induced immunosuppression (at the time of entering the cohort)? |
`pregnancy_bl` | Is the person included in the cohort pregnant (at the time of entering the cohort)? |

## Distribution

File | Format |
--- | --- | ---
`vaccine_effectiveness_synthetic_pop_10k_v.1.1.0` | `csv` |